Last checked at 20 Oct 2023 15:49
20 October 2023
Convatec Group Plc ("Convatec" or "the Company") Director/PDMR Shareholding
The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of £0.10 pence each in the share capital of the Company ("Shares").
On 19 October 2023, Constantin Coussios, Non-Executive Director and PDMR, purchased 4,977 Shares at an average price of £1.9953 per Share. Constantin Coussios' resulting shareholding is now a total of 23,278 Shares.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 | Details of the person discharging managerial responsibilities/person closely associated | |||
a) | Name | Constantin Coussios | ||
2 | Reason for the notification | |||
a) | Position/Status | Non-Executive Director | ||
b) | Initial notification/Amendment | Initial notification | ||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
a) | Name | Convatec Group Plc | ||
b) | LEI | 213800LS272L4FIDOH92 | ||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 10p each in Convatec Group Plc ("Shares") GB00BD3VFW73 | ||
b) | Nature of the transaction | Purchase of shares on 19 October 2023 | ||
c) | Price(s) and volume(s) | Price(s) £1.9884 £2.0006 | Volume(s) 2,497 2,480 | |
d) | Aggregated information - Aggregated volume - Price |
4,977 £9,926.62 *excluding dealing charges | ||
e) | Date of the transaction | 2023-10-19 | ||
f) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||
Enquiries
Kate Postans, VP Investor Relations +44 (0)782 644 7807
ir@convatec.com
Convatec Group Plc's LEI code is 213800LS272L4FIDOH92
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence care and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE: CTEC). To learn more about Convatec, please visit www.convatecgroup.com.